Evidence map›Paper›PMID 35353877›Full record

ArticlePLoS pathogens2022

Identification of distinct capsule types associated with Serratia marcescens infection isolates.

Mark T Anderson, Stephanie D Himpsl, Lindsay A Mitchell, Leandra G Kingsley, Elizabeth P Snider, Harry L T Mobley

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. A standardized workflow for typing S. marcescens outbreaks using FT-IR spectroscopy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Infection characteristics amongbioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Genomic characterization of two carbapenem-resistantFrontiers in cellular and infection microbiology · 2023
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mark T AndersonUniversity of Michigan, Michigan Medicine, Department of Microbiology and Immunology, Ann Arbor, Michigan United States of America.ORCID 0000-0001-5097-3597
Stephanie D HimpslUniversity of Michigan, Michigan Medicine, Department of Microbiology and Immunology, Ann Arbor, Michigan United States of America.
Lindsay A MitchellUniversity of Michigan, Michigan Medicine, Department of Microbiology and Immunology, Ann Arbor, Michigan United States of America.
Leandra G KingsleyUniversity of Michigan, Michigan Medicine, Department of Microbiology and Immunology, Ann Arbor, Michigan United States of America.
Elizabeth P SniderUniversity of Michigan, Michigan Medicine, Department of Microbiology and Immunology, Ann Arbor, Michigan United States of America.
Harry L T MobleyUniversity of Michigan, Michigan Medicine, Department of Microbiology and Immunology, Ann Arbor, Michigan United States of America.
Michigan United · US

Funding

Fitness of gram-negative pathogens during bacteremiaR01AI134731 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BACHMAN, MICHAEL ABBOTT, MOBLEY, HARRY L. · 2019 to 2022
$2.8M
Genetic variation of the Serratia marcescens capsule polysaccharide locus and its contribution to bloodstream infectionR21AI148767 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDERSON, MARK T. · 2020 to 2021
$429k
NIAID NIH HHS R01 AI134731NIAID NIH HHS R21 AI148767
6 · The paper itself

Abstract

Serratia marcescens is a versatile opportunistic pathogen that can cause a variety of infections, including bacteremia. Our previous work established that the capsule polysaccharide (CPS) biosynthesis and translocation locus contributes to the survival of S. marcescens in a murine model of bacteremia and in human serum. In this study, we determined the degree of capsule genetic diversity among S. marcescens isolates. Capsule loci (KL) were extracted from >300 S. marcescens genome sequences and compared. A phylogenetic comparison of KL sequences demonstrated a substantial level of KL diversity within S. marcescens as a species and a strong delineation between KL sequences originating from infection isolates versus environmental isolates. Strains from five of the identified KL types were selected for further study and electrophoretic analysis of purified CPS indicated the production of distinct glycans. Polysaccharide composition analysis confirmed this observation and identified the constituent monosaccharides for each strain. Two predominant infection-associated clades, designated KL1 and KL2, emerged from the capsule phylogeny. Bacteremia strains from KL1 and KL2 were determined to produce ketodeoxynonulonic acid and N-acetylneuraminic acid, two sialic acids that were not found in strains from other clades. Further investigation of KL1 and KL2 sequences identified two genes, designated neuA and neuB, that were hypothesized to encode sialic acid biosynthesis functions. Disruption of neuB in a KL1 isolate resulted in the loss of sialic acid and CPS production. The absence of sialic acid and CPS production also led to increased susceptibility to internalization by a human monocytic cell line, demonstrating that S. marcescens phagocytosis resistance requires CPS. Together, these results establish the capsule genetic repertoire of S. marcescens and identify infection-associated clades with sialic acid CPS components.

Indexed as

BacteremiaSerratia InfectionsAnimalsHumansMiceN-Acetylneuraminic AcidPhylogenySerratia marcescensN-Acetylneuraminic Acid

Identifiers

PMID35353877
PMCPMC9000132
OpenAlexW4221082877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.